These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24466274)

  • 21. miR-26a/HOXC9 Dysregulation Promotes Metastasis and Stem Cell-Like Phenotype of Gastric Cancer.
    Peng X; Kang Q; Wan R; Wang Z
    Cell Physiol Biochem; 2018; 49(4):1659-1676. PubMed ID: 30205370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
    Zhuang RJ; Bai XX; Liu W
    Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML; Zhang Y; Ma LT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2.
    Zhou H; Guo W; Zhao Y; Wang Y; Zha R; Ding J; Liang L; Hu J; Shen H; Chen Z; Yin B; Ma B
    Int J Oncol; 2014 Jun; 44(6):2050-8. PubMed ID: 24682444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. gga-miR-26a targets NEK6 and suppresses Marek's disease lymphoma cell proliferation.
    Li X; Lian L; Zhang D; Qu L; Yang N
    Poult Sci; 2014 May; 93(5):1097-105. PubMed ID: 24795301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration.
    Zhou J; Ju W; Wang D; Wu L; Zhu X; Guo Z; He X
    PLoS One; 2012; 7(4):e33577. PubMed ID: 22496754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
    Huang Z; Li Q; Luo K; Zhang Q; Geng J; Zhou X; Xu Y; Qian M; Zhang JA; Ji L; Wu J
    Cell Death Dis; 2019 May; 10(5):372. PubMed ID: 31068580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR.
    Castellano L; Dabrowska A; Pellegrino L; Ottaviani S; Cathcart P; Frampton AE; Krell J; Stebbing J
    Nucleic Acids Res; 2017 May; 45(8):4401-4412. PubMed ID: 28126920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
    Lin Y; Chen H; Hu Z; Mao Y; Xu X; Zhu Y; Xu X; Wu J; Li S; Mao Q; Zheng X; Xie L
    FEBS Lett; 2013 Aug; 587(15):2467-73. PubMed ID: 23796420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma.
    Lv M; Zhang X; Li M; Chen Q; Ye M; Liang W; Ding L; Cai H; Fu D; Lv Z
    PLoS One; 2013; 8(7):e67591. PubMed ID: 23861775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma.
    Wang X; Wang X; Zhu Z; Li W; Yu G; Jia Z; Wang X
    Biomed Pharmacother; 2019 Sep; 117():109109. PubMed ID: 31229922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer.
    Zhang B; Liu XX; He JR; Zhou CX; Guo M; He M; Li MF; Chen GQ; Zhao Q
    Carcinogenesis; 2011 Jan; 32(1):2-9. PubMed ID: 20952513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer.
    Zhao XX; Yuan QZ; Mu DP; Sun DW; Bo QA; Pan GZ; Li GQ; Cui T; Ding PP; You FP; Hao L; Wang MX; Zhang J
    Int J Clin Exp Pathol; 2015; 8(1):368-73. PubMed ID: 25755724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach.
    Wang P; Lv L
    Oncotarget; 2016 Dec; 7(49):81367-81376. PubMed ID: 27833076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.
    Li W; Yuan Y; Huang L; Qiao M; Zhang Y
    Diabetes Res Clin Pract; 2012 May; 96(2):187-95. PubMed ID: 22245693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma.
    Qiao B; Wang Q; Zhao Y; Wu J
    Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.